课题基金 / 基金详情

UCLA SPORE in Prostate Cancer

UCLA SPORE in Prostate Cancer
UCLA SPORE 在前列腺癌中的应用
批准号:
8548477
负责人:
ROBERT E REITER
金额:
$215.05万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2018-08-31

项目摘要

项目成果

ROBERT E REITER的其他基金

相似基金

相关文献

中文摘要
翻译
加州大学洛杉矶分校前列腺癌孢子是一个多学科和转化研究项目,专注于开发新的创新方法,以改善前列腺癌患者的诊断、预后和治疗。该项目最初是围绕一小群基础和临床科学家建立的,现在已经扩展到校园周围,吸引了来自化学、纳米技术、干细胞生物学、病理学和放射学等不同学科的人才,专注于前列腺癌问题。这个校园范围内(包括UCLA附属机构)的企业已经带来了重大发现,对前列腺癌患者有潜在的重大影响。这个竞争性更新申请的总体目标是继续在加州大学洛杉矶分校应用人才的多样性
英文摘要
The UCLA Prostate Cancer SPORE is a multidisciplinary and translational research program focused on the development of new and innovative approaches for improving the diagnosis, prognosis, and treatment of prostate cancer patients. Initially built around a small nucleus of basic and clinical scientists, the program has expanded around campus to bring diverse talents from disciplines as varied as Chemistry, Nanotechnology, Stem Cell Biology, Pathology and Radiology to focus on the prostate cancer problem. This campus-wide (including UCLA affiliated-institutions) enterprise has led to significant discoveries with potential major impact on men with prostate cancer. The overall goal of this competitive renewal application is to continue to apply the diversity of talent on the UCLA campus and its sister institutions to the critical and evolving translational challenges in the fied of prostate cancer. To achieve the long-term objectives and goals of our program, the Specific Aims of the UCLA SPORE in Prostate Cancer are: 1. Perform high-impact translational research focused on some of the major challenges in the field of prostate cancer by: 2. Provide organizational infrastructure and novel technologies designed specifically to support the translational research objectives of the SPORE: 3. Develop new prostate cancer researchers and research areas to advance translational research in prostate cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multifunctional immunoPET tracers for pancreatic and prostate cancer
Multifunctional immunoPET tracers for pancreatic and prostate cancer
Multifunctional immunoPET tracers for pancreatic and prostate cancer
Multifunctional immunoPET tracers for pancreatic and prostate cancer
海外基金